Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
James P Quinlan Insider Profile
4 Followers
James P Quinlan, Chief Financial Officer at Medicus Pharma Ltd, holds 210.30K shares in Medicus Pharma Ltd (Ticker: TSE:MDCX). Most recently, James P Quinlan Bought C$1,245 shares of Medicus Pharma Ltd on Jul 29, 2024 for an estimated value of 1.53K.
James P Quinlan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of James P Quinlan's holdings
Insider Roles
Chief Financial Officer
Roles that James P Quinlan holds in companies
Most Profitable Insider Trade
The most profitable trade made by James P Quinlan
James P Quinlan's Trading History
List of latest transactions for each holding click on a transaction to see James P Quinlan's performance on stock
You May Also Like
James P Quinlan insider profile FAQ
What is the percentage of profitable transactions made by James P Quinlan?
The percentage of profitable transactions made by James P Quinlan is ―.
What is the average return per transaction made by James P Quinlan?
The average return per transaction made by James P Quinlan is ―.
What stocks does James P Quinlan hold?
James P Quinlan holds: TSE:MDCX stocks.
What was James P Quinlan’s latest transaction?
James P Quinlan latest transaction was an Informative Buy of C$1.53K.
What was James P Quinlan's most profitable transaction?
James P Quinlan’s most profitable transaction was an Informative Buy of TSE:MDCX stock on July 29, 2024. The return on the trade was 56.80%.
What is James P Quinlan's role in Medicus Pharma Ltd?
James P Quinlan's role in Medicus Pharma Ltd is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.